Skip to content

The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy

The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy: A Prospective, Double Blinded, Placebo Controlled Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01106547
Enrollment
55
Registered
2010-04-20
Start date
2009-08-31
Completion date
2011-10-31
Last updated
2011-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysterectomy, Methylprednisolone, Postoperative Pain

Keywords

abdominal hysterectomy, glucocorticoids, rehabilitation, postoperative pain, analgetics

Brief summary

The purpose of this study is to evaluate the effect of 125 mg methylprednisolone, given intravenously 60-90 minutes before abdominal surgery,on the postoperative rehabilitation after abdominal hysterectomy.Sodium Chloride is the placebo. The following parameters are registered: 1. Pain 3, 6 and 24 hours postoperatively and 2-7 days after surgery. 2. The postoperative use of additional analgesics. 3. Inflammatory parameters before and after surgery. 4. Time until mobilization. 5. Time until discharge.

Interventions

DRUGSodium Chloride 2 ml

Single dose 60-90 min preoperatively

DRUGMethylprednisolone 125mg

Single dose 60-90 minutes preoperatively

Sponsors

Holbaek Sygehus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients having an abdominal hysterectomy on a benign indication. * Patients who speak and understand Danish. * Patients who can give informed consent.

Exclusion criteria

* Diabetics * Regular use of glucocorticoids, opioids or tranquilizers * Regular treatment with immunosuppressives * Alcohol or drug abuse * Morphine intolerance * Age under 18 * Chronic pain disease eg fibromyalgia, rheumatoid arthritis * Malign indication for hysterectomy * BMI over 35 * Decreased kidney function * ASA III or IV

Design outcomes

Primary

MeasureTime frameDescription
Pain 6 hours postoperatively6 hours postoperativelyPain registered by a score on a vas-scale from 0-10 during mobilization and during rest 6 hours postoperatively
Pain 3 hours postoperatively3 hours postoperativelyPain registered by a score on a vas-scale from 0-10 during mobilization and during rest 3 hours postoperatively
Pain 24 hours postoperatively24 hours postoperativelyPain registered by a score on a vas-scale from 0-10 during mobilization and during rest 24 hours postoperatively
Pain2-7 days postoperativelyPain registered by a score on a vas-scale from 0-10 during mobilization and during rest once daily from 2nd-7th postoperative day

Secondary

MeasureTime frameDescription
Time until discharge after surgery0-10 days
Inflammatory parameters0-24 h preoperativelyCRP measured 0-24 hours preoperatively before injection of project medicine.
Use of additional analgesics0-2 daysThe use of other analgesics than paracetamol and diclofenac postoperatively - dosage.
Inflammatory parameter1-2 days postoperativeCRP measured at 10am on the first and second postoperative day.
Adverse effects0-2 days
Postoperative nauseauntil 2 days postoperativelyNumbers of vomits
Use of antiemetics0-2 days postoperativelyDosage of antiemetics during the first 2 days postoperatively
Time until mobilization0-2 days

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026